Christopher C Conlin1, Christine H Feng2, Leonardino A Digma2, Ana E Rodriguez-Soto1, Joshua M Kuperman1, Dominic Holland3, Rebecca Rakow-Penner1, Tyler M Seibert1,2,4, Michael E Hahn1, and Anders M Dale1,3,5
1Department of Radiology, UC San Diego School of Medicine, La Jolla, CA, United States, 2Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, CA, United States, 3Department of Neurosciences, UC San Diego School of Medicine, La Jolla, CA, United States, 4Department of Bioengineering, UC San Diego Jacobs School of Engineering, La Jolla, CA, United States, 5Halıcıoğlu Data Science Institute, UC San Diego, La Jolla, CA, United States
Synopsis
Whole-body DWI is increasingly
used to assess bone involvement in prostate cancer. Multicompartmental
diffusion modeling can outperform conventional DWI techniques for evaluating tumors,
but has yet to be applied to whole-body imaging. In this study, we determined
an optimal multicompartmental model for describing whole-body diffusion and
applied it to examine metastatic bone lesions in vivo. We found that a 4-compartment
model best characterized whole-body diffusion. Compartmental
signal-contributions revealed by this model show improved bone-lesion conspicuity
and may help to assess microstructural changes that accompany prostate-cancer
bone involvement.
Motivation
Whole-body MRI is increasingly being used to detect bone
involvement in prostate cancer.1 Diffusion-weighted imaging
(DWI) and apparent diffusion coefficient (ADC) mapping are important components
of the multiparametric approach recommended for whole-body metastasis screening.2 Recent studies have shown
that multicompartmental diffusion modeling outperforms these conventional DWI
techniques for assessing cancer within the prostate,3 but such modeling has yet to
be applied to whole-body imaging.
In this study, we optimized a multicompartmental model for describing
diffusion signal throughout the body and applied it to examine the diffusion
characteristics of metastatic bone lesions in vivo. The potential
clinical utility of this model was examined by comparing lesion conspicuity on model-derived
images against their conspicuity on conventional DWI.Methods
This prospective study included 30 patients with prostate
cancer who underwent an extended whole-body MRI examination in addition to
routine clinical imaging. Standard-of-care evaluation identified 107 bone
lesions in 25 of these patients.
Whole-body MRI acquisition
MR imaging was performed on a 3T clinical scanner (Discovery
MR750; GE Healthcare). Five stations were imaged for each patient,
corresponding roughly to the head, chest, abdomen, pelvis, and thighs. At each station, an axial volume of
multi-shell diffusion data was acquired using 4 b-values: 0, 500, 1000, and
2000 s/mm2, sampled at 1, 6, 6, and 12 unique diffusion-encoding
gradient directions, respectively (default tensor, TR: 4750ms, TE: 75ms,
matrix: 80×80 resampled to 128×128, FOV: 400mm, slices: 46, slice thickness: 6mm). For anatomical reference, a high
resolution T2-weighted volume was also acquired at each station with
scan-coverage identical to that of the multi-shell DWI volume (TR: 1350ms, TE: 113ms,
matrix: 384×224 resampled to 512×512, FOV: 400mm, slices: 46, slice thickness: 6mm).
MRI data post-processing
Each multi-shell DWI volume was first corrected for
distortions due to B0-inhomogeneity, gradient nonlinearity, and eddy currents.4 The signal intensity of each
DWI volume was corrected to account for noise.5 Isotropic diffusion was
assumed, so directional DWI volumes at each b-value were averaged. Conventional
ADC maps were computed by fitting the DWI data to a monoexponential signal
model.6
Regions of interest (ROIs) were defined on the DWI volumes.
Whole-body ROIs (excluding the head) were defined for 10 patients. In 5
patients without metastases, tissue-specific ROIs were defined in the pelvic
and thigh stations (to avoid respiratory motion artifacts), specifically over
the bladder (including urine), prostate, testes, and subcutaneous fat. In 25
patients, ROIs were defined over each identified bone lesion.
Multicompartmental modeling and analysis
Restriction spectrum imaging (RSI) is a multicompartmental
modeling framework that describes the DWI signal thusly: $$S(b)=\sum_{i=1}^{K}C_ie^{-bD_i}$$ where S(b) denotes the noise-corrected DWI signal at a
particular b-value, K is the number of tissue compartments, Ci
describes the contribution of a particular compartment to the overall signal,
and Di is the compartmental diffusion coefficient. A global fitting
of this model to the DWI data within the 10 whole-body ROIs (~9 million voxels)
was performed,3 with K ranging from 2 to 4.
The relative Bayesian Information Criterion (ΔBIC7) and model-fitting residual
of each model was recorded to evaluate how well it described the whole-body DWI
data. Fitting residual was also examined at the voxel-level and ROI-level
within specific tissues to examine how the fit of each model varied between
anatomical regions.
For the optimal RSI model (the model with lowest ΔBIC), signal-contribution (Ci) maps
were computed for each patient via nonnegative least-squares fitting of the
model to the signal-vs-b-value curve from each voxel.3
Compartmental signal fractions for the optimal model were
computed by normalizing the C value of each compartment by the sum of all C
values: $$$C_i/\sum_{i=1}^{K}C_i$$$. Signal
fractions were compared between bone lesions and other tissues using two-sample
t-tests (α=0.05).
Lesion conspicuity
Bone-lesion conspicuity8 was defined as the
mean signal within the lesion ROI divided by the mean signal within a control
ROI defined by reflecting the lesion ROI laterally across the spine.
Conspicuity was calculated for each lesion on the conventional DWI images, ADC
map, and signal-contribution maps from the optimal RSI model. Paired t-tests (α=0.05) were used to determine if lesion
conspicuity was significantly higher on RSI maps compared to conventional images.Results
The lowest BIC and model-fitting residuals were observed from
the 4-compartment model (Figures 1 and 2). Optimal D values for the
4-compartment model were 0, 1.2e-3, 2.9e-3, and >3.0e-2mm2/s.
Signal-contribution (Ci) maps computed using this model are shown in
Figure 3 for a patient with bone lesions, alongside conventional MR images. Figure
4 illustrates the significant increase in lesion conspicuity on RSI C1
and C2 maps compared to conventional ADC maps (C1:
P<0.001, C2: P=0.02) or DWI images (C1: P<0.001, C2:
P<0.04). Figure 5 shows that compartmental signal fraction was significantly
higher in compartments 1 (P<0.04) and 2 (P<0.01) of lesions than in other
tissues.Discussion
An optimized 4-compartment
RSI model provides a more comprehensive characterization of whole-body
diffusion than conventional DWI methods. Compartmental signal-contributions
revealed by this model may help to assess microstructural changes that accompany
prostate-cancer bone involvement. Improved conspicuity of lesions on RSI signal-contribution
maps may help to discriminate between cancerous and benign tissues during
whole-body cancer screening.Acknowledgements
Funding provided by:
Department of Defense Congressionally Directed Medical Research Program. Grant Number: DoD W81XWH‐17‐1‐0618
Prostate Cancer Foundation
National Institute of Biomedical Imaging and Bioengineering. Grant Number: K08 EB026503
References
1. Larbi A, Omoumi P, Pasoglou V, et al.: Whole-body
MRI to assess bone involvement in prostate cancer and multiple myeloma:
comparison of the diagnostic accuracies of the T1, short tau inversion recovery
(STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur
Radiol 2019; 29:4503–4513.
2. Padhani AR, Lecouvet FE, Tunariu N, et al.:
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines
for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance
Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate
Cancer. Eur Urol 2017; 71:81–92.
3. Conlin CC, Feng CH, Rodriguez‐Soto
AE, et al.: Improved Characterization of Diffusion in Normal and Cancerous
Prostate Tissue Through Optimization of Multicompartmental Signal Models. J
Magn Reson Imaging (Early View).
4. Holland D, Kuperman JM, Dale AM: Efficient
correction of inhomogeneous static magnetic field-induced distortion in Echo
Planar Imaging. NeuroImage 2010; 50:175–183.
5. Karunamuni RA, Kuperman J, Seibert TM, et al.:
Relationship between kurtosis and bi-exponential characterization of high
b-value diffusion-weighted imaging: application to prostate cancer. Acta Radiol
2018; 59:1523–1529.
6. Vidić I, Egnell L, Jerome NP, et al.: Modeling the
diffusion-weighted imaging signal for breast lesions in the b = 200 to 3000
s/mm2 range: quality of fit and classification accuracy for different
representations. Magn Reson Med 2020; 84:1011–1023.
7. Schwarz G: Estimating the Dimension of a Model. Ann
Stat 1978; 6:461–464.
8. White NS, McDonald CR, Farid N, Kuperman JM,
Kesari S, Dale AM: Improved Conspicuity and Delineation of High-Grade Primary
and Metastatic Brain Tumors Using “Restriction Spectrum Imaging”: Quantitative
Comparison with High B-Value DWI and ADC. Am J Neuroradiol 2013;
34:958–964.